ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Bactolac Pharmaceutical, INC.

Official 2024 U.S. DOL Form 5500 summary for Bactolac Pharmaceutical, INC. (Bactolac Pharmaceutical 401(k) Plan · EIN 11-3259533 · PN 001): $13.81M net assets, 1,002 active participants, and $62.21 per $10,000 (62.21 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorBactolac Pharmaceutical, INC.
Filing IdentifierBactolac Pharmaceutical 401(k) Plan · EIN 11-3259533 · PN 001
Plan Category & State401(k) Defined Contribution (NY)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$13.81M
Active Participants1,002
Direct Admin Fee Rate$62.21 per $10,000 (62.21 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderADP Retirement Services
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI